Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.

AIM: To describe the rationale and design of a pilot program to implement and evaluate pharmacogenetic (PGx) testing in a primary care setting. STUDY RATIONALE: Several factors have impeded the uptake of PGx testing, including lack of provider knowledge and challenges with operationalizing PGx testing in a clinical practice setting. STUDY DESIGN: We plan to compare two strategies for the implementation of PGx testing: a pharmacist-initiated testing arm compared with a physician-initiated PGx testing arm. Providers in both groups will be required to attend an introduction to PGx seminar. Anticipated results: We anticipate that providers in the pharmacist-initiated group will be more likely to order PGx testing than providers in the physician-initiated group. CONCLUSION: Overall, we aim to generate data that will inform an effective delivery model for PGx testing and to facilitate a seamless integration of PGx testing in primary care practices.

Duke Scholars

Author Susanne B Haga Medicine, General Internal Medicine

Author Nancy Marie Allen LaPointe Medicine, Cardiology

Author Alex Han Cho Medicine, General Internal Medicine

Author Shelby Derene Reed Population Health Sciences

Author Geoffrey Steven Ginsburg Medicine, Cardiology